TSPO and breast cancer: The heterogeneity of cell types expressing TSPO in metastatic deposits was also proved by Zheng and colleagues [35] after subcutaneous inoculation of the high TSPO MDA-MB-231 breast cancer line and low TSPO MCF-7.